The locally recurrent rectal cancer quality of life study
- Conditions
- Health-related quality of life and survivorship in locally recurrent rectal cancerCancer
- Registration Number
- ISRCTN13692671
- Lead Sponsor
- niversity of Leeds
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 320
Workstream I:
1.1 Aged over or equal to 18 years
1.2 Radiological and/or histological diagnosis of locally recurrent rectal cancer
1.3 Undergone treatment for locally recurrent rectal cancer within the last 2 years
1.4 Able to provide informed written consent to participate
1.5 Able to read and write in the target language.
Workstream II:
2.1 Aged over or equal to 18 years
2.2 New radiological and/or histological diagnosis of locally recurrent rectal cancer
2.3 Able to provide informed written consent to participate
2.4 Able to read and write in the target language.
Workstream III:
3.1 Aged over or equal to 18 years
3.2 Treated for locally recurrent rectal cancer and are disease-free for more than 3 years
3.3 Able to provide informed written consent to participate
3.4 Able to read and write in the target language
1. Patients with cognitive impairment
2. Patients who are in remission from treatment of primary rectal cancer with no evidence of local recurrence
3. Patients who are receiving treatment for distant metastatic disease following previous treatment of rectal cancer with no evidence of local recurrence
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Health-related quality of life assessed using the LRRC-QoL questionnaire at baseline, 10 - 14 days, 3, 6 and 12 months.
- Secondary Outcome Measures
Name Time Method The survivorship issues relevant to patients who have undergone treatment for locally recurrent rectal cancer, these will be established through using qualitative interviews at a single time point.